Babusha (@kalrababusha) 's Twitter Profile
Babusha

@kalrababusha

ID: 333947833

calendar_today12-07-2011 10:18:28

24 Tweet

71 Followers

235 Following

Aditya Raj Kaul (@adityarajkaul) 's Twitter Profile Photo

India is cheering for Neeraj Chopra! He is currently topping the charts in first two rounds! Third happening now! C’mon Neeraj! Get the gold, boy! 🇮🇳 #Tokyo2020

India is cheering for Neeraj Chopra! He is currently topping the charts in first two rounds! Third happening now! C’mon Neeraj! Get the gold, boy! 🇮🇳 #Tokyo2020
Pritesh Patel (@docpriteshpatel) 's Twitter Profile Photo

If you treat cancer and have 5 minutes to spare, read about my little boy💔 #JCO ASCO Publications #btsm My Beautiful Boy | Journal of Clinical Oncology ascopubs.org/doi/full/10.12…

TMC Radiation Oncology (@radonctmc) 's Twitter Profile Photo

Supriya Chopra Babusha & team report encouraging PFS + OS in 58 pts with oligometastatic & oligorecurrent cervical cancer who received potentially radical doses of RT to relapsed/metastatic site with 56% receiving chemo in this latest IJROBP - The Red Journal paper

<a href="/supriyasastri/">Supriya Chopra</a> <a href="/kalrababusha/">Babusha</a> &amp; team report encouraging PFS + OS in 58 pts with oligometastatic &amp; oligorecurrent cervical cancer who received potentially radical doses of RT to relapsed/metastatic site with 56% receiving chemo in this latest <a href="/IJROBP/">IJROBP - The Red Journal</a> paper
Max Niyazi (@maxniyazi) 's Twitter Profile Photo

So happy to finally share results of our STEREOBRAIN trial - a thread  Great thanks to Radiotherapy & Oncology Trial design: ➡️SRS vs WBRT (contemporary cohort, same criteria and center) ➡️Single isocenter technique  ➡️N=110 ➡️ 4-10 mets, no SCLC thegreenjournal.com/article/S0167-… Results:

IJROBP - The Red Journal (@ijrobp) 's Twitter Profile Photo

These French GFRU prostate RT guidelines always seem to be very popular! Many thoughtful refinements (but still arguing with NRG Oncology) 😂😂😂 At: redjournal.org/article/S0360-…

These French GFRU prostate RT guidelines always seem to be very popular! 
Many thoughtful refinements (but still arguing with <a href="/NRGonc/">NRG Oncology</a>) 😂😂😂
At: redjournal.org/article/S0360-…
Matt Cooperberg (@dr_coops) 's Twitter Profile Photo

ICYMI (I did): very important study from Thomas Hope Jeremie Calais finding very high false-positive rate for "low-volume metastatic" disease on bone scan, using PSMA PET as gold standard. Meaning STAMPEDE H may be wrong, and studies of M1 local tx MUST be repeated in PSMA era.

Chris Parker (@pcaparker) 's Twitter Profile Photo

We now use 20 fractions for prostate bed radiotherapy: Salvage Radiation Therapy After Radical Prostatectomy: Analysis of Toxicity by Dose-Fractionation in the RADICALS-R… pubmed.ncbi.nlm.nih.gov/37150260/

EANO (@eanoassociation) 's Twitter Profile Photo

#RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade #Gliomas in Adults ascopubs.org/doi/10.1200/JC… #btsm #neuroradiology Journal of Clinical Oncology

Evan Thomas MD/PhD (@evanthomas84) 's Twitter Profile Photo

I'm incredibly excited to announce opening of our new sham-controlled RCT of #radiosurgery for #spasticity in patients with #spinalcordinjury, #CerebralPalsy, #stroke. Thanks to Varian for funding & to my colleague & tx inventor, Dr Pantaleo Romanelli #Neurosurgery #pmr

I'm incredibly excited to announce opening of our new sham-controlled RCT of #radiosurgery for #spasticity in patients with #spinalcordinjury, #CerebralPalsy, #stroke. Thanks to <a href="/VarianMedSys/">Varian</a> for funding &amp; to my colleague &amp; tx inventor, Dr Pantaleo Romanelli 

#Neurosurgery #pmr
Tom Powles (@tompowles1) 's Twitter Profile Photo

Enfortumab vedotin & Pembrolizumab improving PFS & OS by 55% & 53% respectively compared to platinum based chemo in 1st line UC (+avelumab in 30%). Chemo has not been beaten before (despite multiple efforts). RR and CR of 68% & 29% is hard to beat. DOR not reached (1/3)#ESMO2023

Enfortumab vedotin &amp; Pembrolizumab improving PFS &amp; OS by 55% &amp; 53% respectively compared to platinum based chemo in 1st line UC (+avelumab in 30%).  Chemo has not been beaten before (despite multiple efforts). RR and CR of 68% &amp; 29% is hard to beat. DOR not reached (1/3)#ESMO2023
Shankar Siva (@_shankarsiva) 's Twitter Profile Photo

Laura Dawson speaks to 2 decades of experience with liver SABR; it’s been a long history of advances; some important tips on delayed contrast imaging in HCC, use lorazepam in select cases; tips on interpreting bright T1 ablation zones (not cancer); margin recipes #radonc #SABR2023

<a href="/ldawsonmd/">Laura Dawson</a> speaks to 2 decades of experience with liver SABR; it’s been a long history of advances; some important tips on delayed contrast imaging in HCC, use lorazepam in select cases; tips on interpreting bright T1 ablation zones (not cancer); margin recipes #radonc #SABR2023
Ashok Mruthyunjaya (@ashokmruthyu) 's Twitter Profile Photo

Exorbitant Hospital Bills!!!! My Father in law had stomach pain was admitted to Manipal hospital. Doctors exmained him and told us he has tumours in intestine and need immediate surgery. Luckily he had insurance and the doctors quoted an estimate of 5 Lakh. Somehow got it

Exorbitant Hospital Bills!!!!

My Father in law had stomach pain was admitted to Manipal hospital. Doctors exmained him and told us he has tumours in intestine and need immediate surgery.

Luckily he had insurance and the doctors quoted an estimate of 5 Lakh. Somehow got it
The Lancet Gastroenterology & Hepatology (@lancetgastrohep) 's Twitter Profile Photo

New research - Liu et al - Systemic therapy with or without local intervention for oligometastatic oesophageal squamous cell carcinoma (ESO-Shanghai 13): an open-label, randomised, phase 2 trial thelancet.com/journals/langa… #GITwitter #OncTwitter OncoAlert

New research - Liu et al - Systemic therapy with or without local intervention for oligometastatic oesophageal squamous cell carcinoma (ESO-Shanghai 13): an open-label, randomised, phase 2 trial

thelancet.com/journals/langa…

#GITwitter #OncTwitter <a href="/OncoAlert/">OncoAlert</a>
Elekta (@elekta) 's Twitter Profile Photo

Roses are red, violets are blue, To all who care for people with cancer, We appreciate you. We know how much everyone loves our MLC 💜! Happy Valentine's Day from Elekta! *In #radiotherapy, an MLC (pictured here) is used to shape the radiation beam generated by a linac. ❤️🌹❤️